Prof Androulla Efstratiou – GBS screening & lab diagnostics in UK & continental Europe

Home/Prof Androulla Efstratiou – GBS screening & lab diagnostics in UK & continental Europe

Prof Androulla Efstratiou – GBS screening & lab diagnostics in UK & continental Europe

Prof Androulla Efstratiou spoke first about microbiological screening. Currently:

  • Most units did not use a sensitive test to detect GBS carriage*.
  • Risk factors recommended by RCOG to select women for antibiotics in labour were poor at predicting GBS carriage.
  • Almost 1 in 5 women who had no known risk factors in fact carried GBS.
  • Many GBS carriers were falsely given a negative result from a standard test.

*Since the presentation, Prof Efstratiou has confirmed to us that the ECM test is not routinely available from PHE laboratories.

“It is extremely important to have a very sensitive and also a Standardised Microbiological Screening Test. Currently Public Health England (PHE) offers a standard operating protocol called B58, and this is the UK Standard for Microbiological Investigations for Processing Swabs for GBS carriage.”
Prof Androulla Efstratiou, Director, WHO Global Collaborating Centre for Diphtheria & Streptococcal Infections, Visiting Professor Imperial College Faculty of Medicine

Click here to read the transcript

Click here to view the slides

By | 2017-01-11T18:39:45+00:00 June 15th, 2016|2015 GBS Conference|0 Comments